Poland· PL-100035640
Krople żołądkowe Aflofarm
A medicinal product containing produkt złożony, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Produkt złożony
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990669615
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c19f35ce-1c5d-426d-a586-73e12cb25904 GET /v1/drugs/c19f35ce-1c5d-426d-a586-73e12cb25904?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople doustne",
"source": "urpl",
"strength": "-",
"packaging": "05909990669615 ¦ OTC ¦ 2883\n1 butelka 35 g",
"substance": "Valerianae tinctura DER 1:4,0-4,5 (ekstrahent - etanol 70% v/v) 25 g + Menthae piperitae tinctura cum menthae piperitae aetheroleo DER 1:18-20 (ekstrahent - etanol 90% v/v) 25 g + Amara tinctura DER 1:3,8-4,5 (ekstrahent - etanol 70% v/v) 25 g + Hyperici intractum DER 1:1 (ekstrahent - etanol 96% v/v) 25 g",
"common_name": "Produkt złożony",
"pl_product_id": "100035640",
"pozwolenie_nr": "06696",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about produkt złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.